Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Sr-89
DRUG
2 trials
Sponsors
Radiation Therapy Oncology Group
, Peking Union Medical College Hospital
Conditions
Bone Metastases
Breast Cancer
Lung Cancer
Metastatic Cancer
Pain
Prostate Cancer
Thyroid Neoplasm Follicular
Phase 3
Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
Completed
NCT00365105
Radiation Therapy Oncology Group
Breast Cancer, Lung Cancer, Metastatic Cancer +2
Start: 2006-07-11
End: 2017-02-27
Updated: 2024-09-20
Phase 4
Efficacy of Sr-89 for Differentiated Thyroid Cancer With Bone Metastases
NCT05466812
Peking Union Medical College Hospital
Bone Metastases, Thyroid Neoplasm Follicular
Start: 2022-07-13
End: 2025-07-13
Target: 20
Updated: 2022-07-20
Related Papers
Randomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: report of the NRG Oncology RTOG 0517 trial.
2018-08-09
10 citations